I agree that this site is using cookies. You can find further informations here.
X
Capelli, Debora
23  results:
OpenAccess-fulltext X
Search for persons X
?
1

Azacitidine Post-Remission Therapy for Elderly Patients wit..:

Oliva, Esther Natalie ; Candoni, Anna ; Salutari, Prassede...
info:eu-repo/semantics/altIdentifier/wos/WOS:000991562000001.  , 2023
Link: https://hdl.handle.net/1..
 
?
2

Overcoming Resistance: FLT3 Inhibitors Past, Present, Futur..:

Capelli, Debora ; Menotti, Diego ; Fiorentini, Alessandro..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454516/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Mechanisms of Resistence of New Target Drugs in Acute Myelo..:

Capelli, Debora
https://openresearchlibrary.org/viewer/d45bab58-518b-4f7e-9abd-b82f9552d1d9.  , 2022
Link: https://openresearchlibr..
 
?
4

Mechanisms of Resistence of New Target Drugs in Acute Myelo..:

Capelli, Debora ; Saraceni, Francesco ; Menotti, Diego..
ISBN:978-1-83881-168-6.  , 2020
Link: https://mts.intechopen.c..
 
?
5

The Time Has Come for Targeted Therapies for AML: Lights an..:

Fiorentini, Alessandro ; Capelli, Debora ; Saraceni, Francesco...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359996/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
6

Minimal Residual Disease in Acute Myeloid Leukemia: Still a..:

Mosna, Federico ; Capelli, Debora ; Gottardi, Michele
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483867/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
7

Complex karyotype, older age, and reduced first-line dose i..:

Mosna, Federico ; Papayannidis, Cristina ; Martinelli, Giovanni...
https://amsacta.unibo.it/id/eprint/4423/4/MOSNA_GOTTARDI_CBF_AML_STUDY_FINAL_Pre-Referee_clean.pdf.  , 2015
Link: https://amsacta.unibo.it..
 
?
8

Azacitidine Post-Remission Therapy for Elderly Patients wit..:

Esther Natalie Oliva ; Anna Candoni ; Prassede Salutari...
https://www.mdpi.com/2072-6694/15/9/2441.  , 2023
Link: https://doi.org/10.3390/..
 
?
9

Azacitidine Post-Remission Therapy for Elderly Patients wit..:

Esther Natalie Oliva ; Anna Candoni ; Prassede Salutari...
Cancer Therapy.  , 2023
Link: https://doi.org/10.3390/..
 
?
10

Overcoming Resistance: FLT3 Inhibitors Past, Present, Futur..:

Debora Capelli ; Diego Menotti ; Alessandro Fiorentini..
Cancer Epidemiology and Prevention.  , 2022
Link: https://doi.org/10.3390/..
 
?
11

Overcoming Resistance: FLT3 Inhibitors Past, Present, Futur..:

Debora Capelli ; Diego Menotti ; Alessandro Fiorentini..
https://www.mdpi.com/2072-6694/14/17/4315.  , 2022
Link: https://doi.org/10.3390/..
 
?
12

The Time Has Come for Targeted Therapies for AML: Lights an..:

Alessandro Fiorentini ; Debora Capelli ; Francesco Saraceni...
https://doi.org/10.1007/s40487-019-00108-x.  , 2020
Link: https://doi.org/10.1007/..
 
?
13

Minimal Residual Disease in Acute Myeloid Leukemia: Still a..:

Federico Mosna ; Debora Capelli ; Michele Gottardi
https://dx.doi.org/10.3390/jcm6060057.  , 2017
Link: https://doi.org/10.3390/..
 
?
14

Minimal Residual Disease in Acute Myeloid Leukemia: Still a..:

Federico Mosna ; Debora Capelli ; Michele Gottardi
http://www.mdpi.com/2077-0383/6/6/57.  , 2017
Link: https://doi.org/10.3390/..
 
?
15

Primary B-cell lymphoblastic lymphoma of the testis:

Flavia Tombolini ; Vito Lacetera ; Guido Gini...
http://www.pagepressjournals.org/index.php/aiua/article/view/5064.  , 2014
Link: https://doi.org/10.4081/..
 
1-15